Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-015839
Filing Date
2025-02-07
Accepted
2025-02-07 06:45:33
Documents
132
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgc-20241231.htm   iXBRL 10-Q 4948272
2 EX-31.1 cgc-ex31_1.htm EX-31.1 17460
3 EX-31.2 cgc-ex31_2.htm EX-31.2 17194
4 EX-32.1 cgc-ex32_1.htm EX-32.1 10355
5 EX-32.2 cgc-ex32_2.htm EX-32.2 10346
  Complete submission text file 0000950170-25-015839.txt   19970692

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgc-20241231.xsd EX-101.SCH 2679423
135 EXTRACTED XBRL INSTANCE DOCUMENT cgc-20241231_htm.xml XML 4023420
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38496 | Film No.: 25599233
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)